Stay updated on CC-122/Nivolumab Combo in Unresectable HCC Clinical Trial
Sign up to get notified when there's something new on the CC-122/Nivolumab Combo in Unresectable HCC Clinical Trial page.

Latest updates to the CC-122/Nivolumab Combo in Unresectable HCC Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedLocations section now shows a general Locations entry with California, Florida, New York, and Texas removed as separate blocks; revision updated to v3.3.3.SummaryDifference0.5%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check42 days agoChange DetectedRevision: v3.3.2 was added and v3.2.0 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check49 days agoChange DetectedThe government funding/status notice about NIH operations has been removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check64 days agoChange DetectedThe two screenshots show the same Study Details page with minor visual/layout updates (formatting, spacing, typography) and no changes to core study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check93 days agoChange DetectedAdded a government-operating-status notice and a version bump to v3.2.0; removed the previous version label v3.1.0.SummaryDifference3%

- Check100 days agoChange DetectedChanged the revision from v3.0.2 to v3.1.0, indicating a minor version update with no substantive content changes.SummaryDifference0.1%

Stay in the know with updates to CC-122/Nivolumab Combo in Unresectable HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CC-122/Nivolumab Combo in Unresectable HCC Clinical Trial page.